Solid Phase Peptide Synthesis Market Share

Geographically, the solid phase peptide synthesis market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to hold largest revenue share by 2036, owing to rising demand for novel antibody and protein-based drugs and the increasing expenditure on research activities in the region. Furthermore, in 2022, the market in North America is evaluated to occupy the largest share in terms of revenue, owing to the favourable regulatory environment for early approval of peptide drugs, accompanied by the presence of advanced healthcare infrastructure in the region. Along with this, North America also has a high prevalence of chronic lifestyle disorders, which is also expected to boost the demand for peptides, which in turn, would contribute to the market growth in the region.

Alternatively, the market in Europe is also anticipated to occupy a significant share in the solid phase peptide synthesis market on account of high investments in solid phase peptide synthesis technologies and a high prevalence of obesity & diabetes in the region. As per the International Diabetes Federation Atlas, in 2019, around 59 million individuals in the age between 20-79 years had diabetes in Europe. Additionally, European region had the highest number of children and adolescents having Type-1 diabetes and the number amounted to 296,500 in total in the same year.